ReFleks Regenerative medicine for fixing joint damage to stop progression to osteoarthritis Queen Mary Innovation » Spinouts » elcella Prof Francesco Dell'Accio Professor of Musculoskeletal Regenerative Medicine and Rheumatology Dr Suzanne Eldridge Senior Lecturer of...
BioPharma Predicting Pre-Eclampsia Pre-eclampsia, a condition affecting pregnant women, remains poorly understood despite affecting up to one in ten pregnancies worldwide. The condition kills 70,000 mothers and half a million babies globally each year. If diagnosed...
BioPharma Predicting dementia nine years before symptoms Researchers at Queen Mary’s Centre of Preventive Neurology have developed a new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis. The new method provides a more...
BioPharma A Combination Therapy for Neovascular Eye Diseases Angiogenesis is a leading cause of eye problems among over 50s – including blindness. Conventional treatments have serious side effects, making them deeply unpleasant for patients. A new peptide therapy...
BioPharma Restorative treatments for osteoarthritis There’s no cure for osteoarthritis. Current treatment for this debilitating joint disease involves managing symptoms and replacing joints. Professor Francesco Dell’Accio and his team have invented three novel and...
